Veru Hopes To Improve The QUALITY Of Drug-Induced Weight Loss

The biotech announced results of the Phase IIb QUALITY trial of enobosarm in older patients taking Wegovy, showing reduced loss of lean mass.

Image of semaglutide, liraglutide injections
(Shutterstock)

More from Alimentary/Metabolic

More from Scrip